Klaria Pharma Holding AB (KLAR) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.004x

Based on the latest financial reports, Klaria Pharma Holding AB (KLAR) has a cash flow conversion efficiency ratio of 0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-82.00K ≈ $-8.82K USD) by net assets (Skr-20.61 Million ≈ $-2.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KLAR days of operational coverage to measure how many days the company can operate on defensive assets alone.

Klaria Pharma Holding AB - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Klaria Pharma Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Klaria Pharma Holding AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Klaria Pharma Holding AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Everest Metals Corporation Ltd AU:EMC	0.027x
Grafton Group plc LSE:GFTU	0.080x
Celulosa Argentina SA BA:CELU	0.013x
Wilton Resources Inc V:WIL	-1.093x
Hua Yang Bhd KLSE:5062	-0.100x
Orion Digital Corp. NASDAQ:ORIO	0.051x
Pantera Silver Corp V:PNTR	-0.027x
Thai Film Industries Public Company Limited BK:TFI	-0.044x

Annual Cash Flow Conversion Efficiency for Klaria Pharma Holding AB (2015–2025)

The table below shows the annual cash flow conversion efficiency of Klaria Pharma Holding AB from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Klaria Pharma Holding AB.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr-3.88 Million ≈ $-417.44K	Skr-35.04 Million ≈ $-3.77 Million	9.032x	+350.12%
2024-12-31	Skr3.31 Million ≈ $355.67K	Skr-11.94 Million ≈ $-1.28 Million	-3.611x	-1539.91%
2023-12-31	Skr41.13 Million ≈ $4.43 Million	Skr-9.06 Million ≈ $-974.79K	-0.220x	+66.31%
2022-12-31	Skr76.08 Million ≈ $8.19 Million	Skr-49.73 Million ≈ $-5.35 Million	-0.654x	-82.97%
2021-12-31	Skr69.42 Million ≈ $7.47 Million	Skr-24.80 Million ≈ $-2.67 Million	-0.357x	-10.92%
2020-12-31	Skr109.59 Million ≈ $11.79 Million	Skr-35.30 Million ≈ $-3.80 Million	-0.322x	-78.73%
2019-12-31	Skr82.11 Million ≈ $8.84 Million	Skr-14.80 Million ≈ $-1.59 Million	-0.180x	-86.99%
2018-12-31	Skr94.70 Million ≈ $10.19 Million	Skr-9.13 Million ≈ $-982.10K	-0.096x	-22.67%
2017-12-31	Skr153.52 Million ≈ $16.52 Million	Skr-12.06 Million ≈ $-1.30 Million	-0.079x	+12.65%
2016-12-31	Skr160.04 Million ≈ $17.22 Million	Skr-14.39 Million ≈ $-1.55 Million	-0.090x	-254.52%
2015-12-31	Skr174.59 Million ≈ $18.79 Million	Skr-4.43 Million ≈ $-476.63K	-0.025x	--

About Klaria Pharma Holding AB

ST:KLAR Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$20.99 Million

Skr195.06 Million SEK

Market Cap Rank

#24979 Global

#502 in Sweden

Share Price

Skr0.79

Change (1 day)

+0.63%

52-Week Range

Skr0.40 - Skr1.22

All Time High

Skr17.00